These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6987783)

  • 21. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
    Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
    Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
    [No Abstract]   [Full Text] [Related]  

  • 23. CD4 T cells and allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    Transplant Proc; 1988 Feb; 20(1):56-60. PubMed ID: 2449753
    [No Abstract]   [Full Text] [Related]  

  • 24. Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time.
    Deng G; Deng R; Yao J; Liao B; Chen Y; Wu Z; Hu H; Zhou X; Ma Y
    Parasitol Res; 2016 Jan; 115(1):407-14. PubMed ID: 26481486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection.
    Ueno T; Yamada A; Ito T; Yeung MY; Gorbatov R; Shimizu T; Abdi R; Sayegh MH; Auchincloss H; Najafian N
    Transplantation; 2011 Sep; 92(5):e26-7. PubMed ID: 21866037
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14.
    Morgan GM; Dellos H; McKenzie IF; Melvold RW; Bailey DW
    Immunogenetics; 1980; 11(4):341-9. PubMed ID: 6159320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
    Vizler C; Jánossy T; Tabi Z; Végh P
    Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the donor's and recipient's metabolic statuses in successful transplantation of a whole skin graft.
    Shumakov VI; Vasilenko VT; Gasanov EK; Piruzyan LA; Saprin AN; Sukhanov VA
    Dokl Biol Sci; 2003; 388():35-7. PubMed ID: 12705125
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokine profile during allogeneic heart transplant rejection.
    Saber LT; Aliberti JC; Silva JS; Rossi MA; Ferraz AS
    Transplant Proc; 1999 Nov; 31(7):2978-81. PubMed ID: 10578356
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperacute rejection of murine skin grafts.
    Eichwald EJ; Dolberg M
    Transplantation; 1977 Jun; 23(6):516-21. PubMed ID: 325719
    [No Abstract]   [Full Text] [Related]  

  • 33. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
    He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
    Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cimetidine does not accelerate skin graft rejection in mice.
    Festen HP; Berden JH; Koene RA
    Clin Exp Immunol; 1980 Apr; 40(1):193-6. PubMed ID: 6993076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice.
    Ohlén C; Kling G; Höglund P; Hansson M; Scangos G; Bieberich C; Jay G; Kärre K
    Science; 1989 Nov; 246(4930):666-8. PubMed ID: 2814488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gal mismatch alone causes skin graft rejection in mice.
    Gock H; Murray-Segal L; Salvaris E; Cowan PJ; D'Apice AJ
    Transplantation; 2002 Sep; 74(5):637-45. PubMed ID: 12352879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term cardiac allograft survival in mice treated with malononitrilamide 715.
    Gerauer K; Maier S; Emmanuilidis K; Chambron N; Zantl N; Pfeffer K; Heidecke CD
    Transplant Proc; 1998 Dec; 30(8):4205-6. PubMed ID: 9865349
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.